Pennant ROA 2018-2026 | PNTG
Current and historical return on assets (ROA) values for Pennant (PNTG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Pennant ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $0.03B | $0.86B | 3.62% |
| 2025-12-31 | $0.03B | $0.80B | 3.73% |
| 2025-09-30 | $0.03B | $0.73B | 3.69% |
| 2025-06-30 | $0.03B | $0.71B | 3.83% |
| 2025-03-31 | $0.03B | $0.67B | 3.89% |
| 2024-12-31 | $0.02B | $0.63B | 3.67% |
| 2024-09-30 | $0.02B | $0.59B | 3.55% |
| 2024-06-30 | $0.02B | $0.56B | 3.39% |
| 2024-03-31 | $0.02B | $0.54B | 2.97% |
| 2023-12-31 | $0.01B | $0.52B | 2.50% |
| 2023-09-30 | $0.01B | $0.51B | 2.34% |
| 2023-06-30 | $0.01B | $0.51B | 2.55% |
| 2023-03-31 | $0.01B | $0.51B | 1.39% |
| 2022-12-31 | $0.01B | $0.51B | 1.19% |
| 2022-09-30 | $0.00B | $0.51B | 0.20% |
| 2022-06-30 | $0.00B | $0.52B | -0.58% |
| 2022-03-31 | $0.00B | $0.52B | 0.57% |
| 2021-12-31 | $0.00B | $0.53B | 0.57% |
| 2021-09-30 | $0.01B | $0.52B | 1.73% |
| 2021-06-30 | $0.01B | $0.51B | 2.36% |
| 2021-03-31 | $0.01B | $0.49B | 2.63% |
| 2020-12-31 | $0.02B | $0.48B | 3.13% |
| 2020-09-30 | $0.01B | $0.46B | 1.51% |
| 2020-06-30 | $0.01B | $0.44B | 1.15% |
| 2020-03-31 | $0.00B | $0.32B | 1.26% |
| 2019-12-31 | $0.00B | $0.20B | 0.99% |
| 2019-06-30 | $0.01B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.072B | $0.948B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |